文献速递头颈部肿瘤放疗放疗物理与技术

头颈癌患者中氧增强MRI首次人体技术转化至MR直线加速器系统

First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer.
PubMed 文献 · Radiother Oncol · 2023-03-03

本研究在体模和15名健康参与者中开发氧增强MRI(OE-MRI)序列,随后评估14例头颈癌(HNC)患者(21个原发或局部淋巴结肿瘤),比较1.5 T诊断MR与MR直线加速器系统的可重复性,结果显示两系统上基线T1重复性优异,肿瘤ΔR1可重复,两系统结果等效。

要点

  • 在健康参与者中鼻腔甲介氧诱导ΔR1显著增加(p < 0.0001),证明OE-MRI可行性。
  • 诊断MR上肿瘤ΔR1重复性系数为0.013 s-1,受试者内变异系数为25%。
  • MR直线加速器上肿瘤ΔR1重复性系数为0.020 s-1,受试者内变异系数为33%。

核心结论

  • 本研究展示了容积动态OE-MRI首次人体转化至MR直线加速器系统,产生可重复的缺氧生物标志物。
  • 诊断MR与MR直线加速器系统上的数据等效。
  • OE-MRI有潜力指导未来生物学引导自适应放疗的临床试验。

研究设计与样本

  • 在体模和15名健康参与者中开发MRI序列。
  • 评估14例HNC患者(21个原发或局部淋巴结肿瘤),测量基线T1及空气与氧气呼吸相之间的1/T1变化(ΔR1)。
  • 比较1.5 T诊断MR与MR直线加速器系统的结果。

主要发现

  • 基线T1在体模、健康参与者和患者中于两系统上均具有优异重复性。
  • 健康参与者鼻腔甲介氧诱导ΔR1显著增加(p < 0.0001),证明OE-MRI可行性。
  • 两MR系统上ΔR1重复性系数为0.023-0.040 s-1。
  • 诊断MR上肿瘤ΔR1重复性系数为0.013 s-1,受试者内变异系数为25%。
  • MR直线加速器上肿瘤ΔR1重复性系数为0.020 s-1,受试者内变异系数为33%;两系统上ΔR1幅度和时间进程趋势相似。

关键数值与推荐

  • 健康参与者鼻腔甲介氧诱导ΔR1显著增加(p < 0.0001)。
  • 两MR系统上ΔR1重复性系数为0.023-0.040 s-1。
  • 诊断MR上肿瘤ΔR1重复性系数为0.013 s-1,受试者内变异系数为25%。
  • MR直线加速器上肿瘤ΔR1重复性系数为0.020 s-1,受试者内变异系数为33%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Tumour hypoxia is prognostic in head and neck cancer (HNC), associated with poor loco-regional control, poor survival and treatment resistance. The advent of hybrid MRI - radiotherapy linear accelerator or 'MR Linac' systems - could permit imaging for treatment adaptation based on hypoxic status. We sought to develop oxygen-enhanced MRI (OE-MRI) in HNC and translate the technique onto an MR Linac system. MATERIALS AND METHODS: MRI sequences were developed in phantoms and 15 healthy participants. Next, 14 HNC patients (with 21 primary or local nodal tumours) were evaluated. Baseline tissue longitudinal relaxation time (T1) was measured alongside the change in 1/T1 (termed ΔR1) between air and oxygen gas breathing phases. We compared results from 1.5 T diagnostic MR and MR Linac systems. RESULTS: Baseline T1 had excellent repeatability in phantoms, healthy participants and patients on both systems. Cohort nasal concha oxygen-induced ΔR1 significantly increased (p < 0.0001) in healthy participants demonstrating OE-MRI feasibility. ΔR1 repeatability coefficients (RC) were 0.023-0.040 s-1 across both MR systems. The tumour ΔR1 RC was 0.013 s-1 and the within-subject coefficient of variation (wCV) was 25% on the diagnostic MR. Tumour ΔR1 RC was 0.020 s-1 and wCV was 33% on the MR Linac. ΔR1 magnitude and time-course trends were similar on both systems. CONCLUSION: We demonstrate first-in-human translation of volumetric, dynamic OE-MRI onto an MR Linac system, yielding repeatable hypoxia biomarkers. Data were equivalent on the diagnostic MR and MR Linac systems. OE-MRI has potential to guide future clinical trials of biology guided adaptive radiotherapy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Dubec MJ, Buckley DL, Berks M, et al. First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer. Radiother Oncol. 2023. PMID: 36870608. doi:10.1016/j.radonc.2023.109592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。